Get the Stockscreener App
0.353
3.29%
-0.012
Pre-market:
.32
-0.033
-9.35%
Enveric Biosciences Inc Stock (ENVB) Forecast
The Enveric Biosciences Inc (ENVB) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $94.00, representing a +26,528% increase from the current price of $0.353. The highest analyst price target is $91.00, and the lowest is $97.00.
Note: Our forecast model does not currently account for dividend and stock split events. This means that our forecast may not be accurate for stocks that have recently experienced either of these events.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ENVB Price Target
Average 95.73
(+27,018% Upside)
Is Enveric Biosciences Inc (ENVB) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 28.58 | Buy |
| STOCH(9,6) | 17.20 | Buy |
| STOCHRSI(14) | 17.21 | Buy |
| MACD(12,26) | -0.025 | Sell |
| ADX(14) | 13.22 | Neutral |
| William %R | -89.53 | Buy |
| CCI(14) | -176.43 | Sell |
Buy: 4
Sell: 2
Neutral: 1
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.4325
Sell
|
0.4197
Sell
|
| MA20 |
0.4726
Sell
|
0.4452
Sell
|
| MA50 |
0.4676
Sell
|
0.473
Sell
|
| MA100 |
0.4934
Sell
|
0.5436
Sell
|
| MA200 |
0.7095
Sell
|
0.8046
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, ENVB could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 12 signaling Sell signals and 1 Neutral signals. This might not be a good time to consider opening new positions on ENVB, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 28.58 indicates that ENVB is oversold. This indicates that ENVB price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 17.2 indicates that ENVB is oversold. This indicates that ENVB price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 17.21 indicates that ENVB is oversold. This suggests that ENVB price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 13.22 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -176.43 indicates that ENVB is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term ENVB price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Enveric Biosciences Inc financial reports and earnings history, Enveric Biosciences Inc (ENVB) stock could reach $222.21 by 2030, $854.92 by 2040 and $324.20 by 2050. See the projected annual prices until 2050 of the Enveric Biosciences Inc stock below:
- Enveric Biosciences Inc (ENVB) is expected to reach an average price of $107.23 in 2035, with a high prediction of $120.50 and a low estimate of $107.36. This indicates an $30,278% rise from the last recorded price of $0.353.
- Enveric Biosciences Inc (ENVB) stock is projected to chart a bullish course in 2040, with an average price target of $851.49, representing an $241.12K% surge from its current level. The forecast ranges from a conservative $854.99 to a sky-high $854.92.
- Our analysts predict Enveric Biosciences Inc (ENVB) to jump 196.09K% by 2045, soaring from $692.84 to an average price of $692.55, potentially reaching $711.15. While $692.84 is the low estimate, the potential upside is significant.
- Enveric Biosciences Inc (ENVB) stock is expected to climb by 2050, reaching an average of $300.10, a $84,915% jump from its current level. However, a wide range of estimates exists, with high and low targets of $324.20 and $300.41, respectively, highlighting the market's uncertainty.
Enveric Biosciences Inc Stock (ENVB) Year by Year Forecast
Enveric Biosciences Inc Stock (ENVB) Price Forecast for 2024
Our forecast for ENVB stock price in 2024 now indicates an average price target of $67.43 with a high forecast of $134.22 and a low forecast of $0.649. The average prediction reflects an increase of +19,003% from the last recorded price of $0.353.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $102.36 | $97.00 | $91.00 | +28,896% |
Enveric Biosciences Inc Stock (ENVB) Price Forecast for 2025
Enveric Biosciences Inc Stock (ENVB) is expected to reach an average price of $95.73 in 2025, with a high prediction of $136.31 and a low estimate of $55.14. This indicates an +27,018% rise from the last recorded price of $0.353.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $10.14 | $55.14 | $91.07 | +2,773% |
| February, 2025 | $75.07 | $71.00 | $72.57 | +21,166% |
| March, 2025 | $85.50 | $82.28 | $79.00 | +24,121% |
| April, 2025 | $102.78 | $83.71 | $96.78 | +29,017% |
| May, 2025 | $109.71 | $109.64 | $104.36 | +30,980% |
| June, 2025 | $127.06 | $115.57 | $121.11 | +35,895% |
| July, 2025 | $138.94 | $125.21 | $135.61 | +39,259% |
| August, 2025 | $134.46 | $136.11 | $136.31 | +37,989% |
| September, 2025 | $128.16 | $128.76 | $131.71 | +36,207% |
| October, 2025 | $126.75 | $126.73 | $126.60 | +35,806% |
| November, 2025 | $123.61 | $123.80 | $125.43 | +34,918% |
| December, 2025 | $117.07 | $118.38 | $120.61 | +33,064% |
Enveric Biosciences Inc Stock (ENVB) Price Forecast for 2026
The predicted value for Enveric Biosciences Inc (ENVB) in 2026 is set at an average of $91.30. Estimates vary from a peak of $115.64 to a trough of $66.96, indicating an +25,765% surge from the present price of $0.353.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $113.55 | $115.43 | $115.64 | +32,068% |
| February, 2026 | $111.86 | $112.19 | $114.40 | +31,589% |
| March, 2026 | $108.65 | $108.65 | $110.31 | +30,679% |
| April, 2026 | $104.94 | $105.01 | $106.45 | +29,627% |
| May, 2026 | $100.71 | $100.83 | $102.93 | +28,431% |
| June, 2026 | $96.34 | $96.47 | $99.23 | +27,192% |
| July, 2026 | $91.42 | $91.93 | $94.97 | +25,797% |
| August, 2026 | $86.07 | $86.22 | $89.61 | +24,281% |
| September, 2026 | $81.05 | $81.06 | $84.80 | +22,860% |
| October, 2026 | $76.83 | $76.94 | $79.83 | +21,665% |
| November, 2026 | $72.55 | $72.77 | $75.61 | +20,452% |
| December, 2026 | $64.81 | $66.96 | $70.84 | +18,261% |
Enveric Biosciences Inc Stock (ENVB) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Enveric Biosciences Inc (ENVB) is $34.84, with a high forecast of $61.75 and a low forecast of $7.926. This indicates an +9,769% increase from the last price of $0.353.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $59.86 | $59.89 | $61.75 | +16,859% |
| February, 2027 | $56.24 | $56.41 | $58.40 | +15,833% |
| March, 2027 | $51.00 | $51.03 | $54.83 | +14,347% |
| April, 2027 | $46.77 | $46.79 | $48.46 | +13,148% |
| May, 2027 | $41.98 | $42.32 | $45.52 | +11,792% |
| June, 2027 | $36.84 | $36.89 | $40.71 | +10,336% |
| July, 2027 | $32.57 | $32.69 | $35.58 | +9,126% |
| August, 2027 | $27.98 | $28.04 | $31.36 | +7,826% |
| September, 2027 | $22.50 | $22.55 | $26.83 | +6,275% |
| October, 2027 | $18.34 | $18.56 | $21.35 | +5,097% |
| November, 2027 | $13.19 | $13.83 | $16.93 | +3,637% |
| December, 2027 | $7.926 | $7.926 | $11.60 | +2,145% |
Enveric Biosciences Inc Stock (ENVB) Price Forecast for 2028
In 2028, Enveric Biosciences Inc (ENVB) is projected to reach an average price of $147.44, with a high projection of $293.71 and a low estimate of $1.1679. This indicates an +41,668% rise from the last price of $0.353.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $3.4596 | $3.4988 | $6.5932 | +880.05% |
| February, 2028 | $251.85 | $1.1679 | $198.40 | +71,247% |
| March, 2028 | $219.93 | $223.43 | $242.07 | +62,202% |
| April, 2028 | $245.78 | $259.28 | $246.85 | +69,527% |
| May, 2028 | $298.85 | $270.43 | $277.85 | +84,561% |
| June, 2028 | $313.21 | $297.28 | $293.71 | +88,628% |
| July, 2028 | $280.57 | $282.57 | $276.85 | +79,381% |
| August, 2028 | $271.64 | $282.21 | $280.50 | +76,852% |
| September, 2028 | $283.00 | $286.50 | $281.28 | +80,069% |
| October, 2028 | $270.35 | $280.85 | $277.22 | +76,488% |
| November, 2028 | $254.93 | $237.78 | $239.43 | +72,117% |
| December, 2028 | $260.78 | $258.07 | $251.28 | +73,776% |
Enveric Biosciences Inc Stock (ENVB) Price Forecast for 2029
The 2029 price forecast for Enveric Biosciences Inc Stock (ENVB) is $256.79 on average, with a high prediction of $288.54 and a low estimate of $225.04. This represents an +72,645% increase from the previous price of $0.353.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $265.35 | $254.93 | $255.35 | +75,071% |
| February, 2029 | $269.71 | $271.57 | $268.71 | +76,305% |
| March, 2029 | $282.13 | $273.43 | $273.57 | +79,823% |
| April, 2029 | $279.43 | $280.43 | $280.56 | +79,057% |
| May, 2029 | $286.10 | $286.12 | $288.54 | +80,947% |
| June, 2029 | $273.35 | $273.85 | $281.46 | +77,337% |
| July, 2029 | $266.79 | $267.09 | $270.70 | +75,477% |
| August, 2029 | $258.99 | $260.68 | $264.08 | +73,267% |
| September, 2029 | $250.82 | $250.82 | $256.50 | +70,955% |
| October, 2029 | $240.75 | $240.93 | $246.85 | +68,101% |
| November, 2029 | $232.88 | $233.41 | $236.47 | +65,871% |
| December, 2029 | $224.87 | $225.04 | $228.74 | +63,604% |
Enveric Biosciences Inc Stock (ENVB) Price Forecast for 2030
Enveric Biosciences Inc Stock (ENVB) is expected to reach an average price of $165.73 in 2030, with a high forecast of $222.21 and a low forecast of $109.25. This signifies an +46,849% surge from the last price of $0.353.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $215.01 | $215.06 | $222.21 | +60,808% |
| February, 2030 | $206.44 | $206.51 | $212.69 | +58,383% |
| March, 2030 | $197.62 | $197.91 | $204.07 | +55,883% |
| April, 2030 | $189.52 | $189.56 | $195.37 | +53,588% |
| May, 2030 | $177.33 | $177.50 | $187.16 | +50,135% |
| June, 2030 | $168.36 | $168.42 | $174.81 | +47,593% |
| July, 2030 | $157.79 | $157.88 | $165.94 | +44,599% |
| August, 2030 | $149.06 | $149.09 | $155.36 | +42,128% |
| September, 2030 | $139.24 | $139.56 | $146.40 | +39,345% |
| October, 2030 | $125.90 | $126.00 | $136.89 | +35,567% |
| November, 2030 | $117.34 | $117.64 | $122.79 | +33,141% |
| December, 2030 | $109.12 | $109.25 | $114.93 | +30,811% |
3.66%
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):